Sort
51,570 grants matching “autoimmune disease”
Characterization of risk factors for excessive cardiovascular diseases (CVD) from circulating and cardiovascular tissues of people with well-controlled chronic type 1 diabetes
$1,020,124George L King · Joslin Diabetes Center · U01 · FY2025 · DK
CD4 AND CD8 T CELL EPITOPES RECOGNIZED IN AUTOIMMUNE AND AUTOINFLAMMATORY DISEASES
$1,020,000Lawrence Stern · Univ Of Massachusetts Med Sch Worcester · N01 · FY2025 · AI
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
$1,020,000Frederick R Blattner · Dnastar, Inc. · R44 · FY2024 · AI
Data Coordination for the AMP Autoimmune and Related (AR) Knowledge Portal Part B
$1,020,000Lara M Mangravite · Sage Bionetworks · U24 · FY2022 · AG
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease
$1,019,854Jeremy H. Herskowitz · University Of Alabama At Birmingham · R01 · FY2020 · AG
NADPH Oxidase p47phox-Mediated Auto-Inflammation and Autoimmunity
$1,019,758Sharon Jackson · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Safety of Estrogen in Lupus Erythematosus
$1,019,677Hospital For Joint Diseases Ortho Inst · U01 · FY2002 · AR
Novel approaches for the treatment of autoimmune disease
$1,019,657Sunil Kannanganat Sidharthan · Astero Erado Inc · R44 · FY2025 · AI
Depleting autoantibodies for the treatment of autoimmunity
$1,019,427Sunil Kannanganat Sidharthan · Astero Erado Inc · R44 · FY2024 · AI
Molecular Mechanisms Of Cell Adhesion And Invasion
$1,019,179Steven Akiyama · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES
Mechanisms of varicella virus-induced multisystem disease using a primate model
$1,019,143Ravi Mahalingam · University Of Colorado Denver · P01 · FY2020 · AG
Targeted Therapies for Myasthenia Gravis
$1,018,947Henry J Kaminski · Saint Louis University · R24 · FY2007 · EY
IGF::OT::IGF RD - A CLOUD COMPUTING PLATFORM FOR CYTOMETRY, SBIR TOPIC 59, PHASE
$1,018,697Nikesh Kotecha · Cytobank, Inc. · N44 · FY2013 · HL
Development of a Precision Medicine-based Diagnostic Tool for Membranous Nephropathy
$1,018,450Christopher P Larsen · Nephropathology Associates · R44 · FY2022 · DK
Transcriptional Regulation of Immune Cell Development, Activation and Functions
$1,018,340Jinfang Zhu · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Genetics, Natural History, and Pathophysiology of Behcet's Disease
$1,018,179Daniel Kastner · National Human Genome Research Institute · ZIA · FY2014 · HG
Genetics, Pathophysiology, and Treatment of Recessive Autoinflammatory Diseases
$1,018,179Daniel Kastner · National Human Genome Research Institute · ZIA · FY2014 · HG
Genetic Analysis of Complex Inflammatory Disorders
$1,018,179Daniel Kastner · National Human Genome Research Institute · ZIA · FY2014 · HG
STUDIES TO EVALUATE THE POTENTIAL FOR ENVIRONMENTAL&THERAPEUTIC AGENTS TO INDUCE IMMUNOTOXICITY - In vitro
$1,017,885Florence Burleson · Brt-Burleson Research Technologies, Inc. · N01 · FY2019 · ES
Human Genetic Analysis Resource
$1,017,600Robert C. Elston · Case Western Reserve University · P41 · FY2007 · RR
AUTOIMMUNITY CENTERS OF EXCELLENCE
$1,016,892Columbia University Health Sciences · U19 · FY2001 · AI
Comprehensive multimodal analysis of patients with neuroimmunological diseases
$1,016,407Bibiana Bielekova · National Institute Of Neurological Disorders And Stroke · ZIA · FY2014 · NS
Depleting autoantibodies for the treatment of autoimmunity
$1,015,992Sunil Kannanganat Sidharthan · Astero Erado Inc · R44 · FY2023 · AI
Cellular and Molecular Pathways for Hearing Restoration in the Adult Inner Ear
$1,015,840Michael Hoa · National Institute On Deafness And Other Communication Disorders · ZIA · FY2019 · DC
Development of 7HP349, an oral integrin activator to enhance therapeutic responses to immune checkpoint inhibitors
$1,015,591Upendra Marathi · 7 Hills Pharma, Llc · R44 · FY2021 · CA